[PHARMA] YoY TTM Result on 30-Jun-2017 [#2]

Announcement Date
16-Aug-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Jun-2017 [#2]
Profit Trend
QoQ- -11.87%
YoY- -41.41%
Quarter Report
View:
Show?
TTM Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 2,898,216 2,572,302 2,388,351 2,234,292 2,295,554 2,113,938 2,002,411 6.35%
PBT -189,383 72,267 75,814 61,919 97,079 126,467 109,249 -
Tax 43,048 -23,482 -26,481 -21,162 -26,952 -26,277 -41,209 -
NP -146,335 48,785 49,333 40,757 70,127 100,190 68,040 -
-
NP to SH -145,739 48,386 48,260 40,668 69,407 99,663 66,756 -
-
Tax Rate - 32.49% 34.93% 34.18% 27.76% 20.78% 37.72% -
Total Cost 3,044,551 2,523,517 2,339,018 2,193,535 2,225,427 2,013,748 1,934,371 7.84%
-
Net Worth 357,891 518,564 519,642 542,147 524,177 528,477 502,293 -5.48%
Dividend
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Div 22,204 40,348 51,929 38,883 64,750 88,011 44,519 -10.93%
Div Payout % 0.00% 83.39% 107.60% 95.61% 93.29% 88.31% 66.69% -
Equity
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Net Worth 357,891 518,564 519,642 542,147 524,177 528,477 502,293 -5.48%
NOSH 261,705 261,229 259,821 259,400 258,981 259,057 258,914 0.17%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin -5.05% 1.90% 2.07% 1.82% 3.05% 4.74% 3.40% -
ROE -40.72% 9.33% 9.29% 7.50% 13.24% 18.86% 13.29% -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 1,109.43 987.13 919.23 861.33 886.38 816.01 773.39 6.19%
EPS -55.79 18.57 18.57 15.68 26.80 38.47 25.78 -
DPS 8.50 15.50 20.00 15.00 25.00 34.00 17.20 -11.07%
NAPS 1.37 1.99 2.00 2.09 2.024 2.04 1.94 -5.62%
Adjusted Per Share Value based on latest NOSH - 259,400
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 201.09 178.48 165.72 155.03 159.28 146.68 138.94 6.34%
EPS -10.11 3.36 3.35 2.82 4.82 6.92 4.63 -
DPS 1.54 2.80 3.60 2.70 4.49 6.11 3.09 -10.94%
NAPS 0.2483 0.3598 0.3606 0.3762 0.3637 0.3667 0.3485 -5.48%
Price Multiplier on Financial Quarter End Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 -
Price 2.22 2.84 2.88 4.58 5.50 7.13 4.61 -
P/RPS 0.20 0.29 0.31 0.53 0.62 0.87 0.60 -16.71%
P/EPS -3.98 15.29 15.51 29.21 20.52 18.53 17.88 -
EY -25.13 6.54 6.45 3.42 4.87 5.40 5.59 -
DY 3.83 5.46 6.94 3.28 4.55 4.77 3.73 0.44%
P/NAPS 1.62 1.43 1.44 2.19 2.72 3.50 2.38 -6.20%
Price Multiplier on Announcement Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 19/08/20 23/08/19 17/08/18 16/08/17 19/08/16 17/08/15 21/08/14 -
Price 4.42 2.66 3.11 4.19 5.62 5.65 4.62 -
P/RPS 0.40 0.27 0.34 0.49 0.63 0.69 0.60 -6.52%
P/EPS -7.92 14.33 16.74 26.73 20.97 14.69 17.92 -
EY -12.62 6.98 5.97 3.74 4.77 6.81 5.58 -
DY 1.92 5.83 6.43 3.58 4.45 6.02 3.72 -10.42%
P/NAPS 3.23 1.34 1.56 2.00 2.78 2.77 2.38 5.21%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment